Cite
Kim ST, Jang HL, Lee J, et al. Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer. Transl Oncol. 2015;8(4):288-94doi: 10.1016/j.tranon.2015.06.001.
Kim, S. T., Jang, H. L., Lee, J., Park, S. H., Park, Y. S., Lim, H. Y., Choi, M. G., Bae, J. M., Sohn, T. S., Noh, J. H., Kim, S., Kim, K. M., Kang, W. K., & Park, J. O. (2015). Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer. Translational oncology, 8(4), 288-94. https://doi.org/10.1016/j.tranon.2015.06.001
Kim, Seung Tae, et al. "Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer." Translational oncology vol. 8,4 (2015): 288-94. doi: https://doi.org/10.1016/j.tranon.2015.06.001
Kim ST, Jang HL, Lee J, Park SH, Park YS, Lim HY, Choi MG, Bae JM, Sohn TS, Noh JH, Kim S, Kim KM, Kang WK, Park JO. Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer. Transl Oncol. 2015 Aug;8(4):288-94. doi: 10.1016/j.tranon.2015.06.001. PMID: 26310375; PMCID: PMC4562974.
Copy
Download .nbib